5 December 2025
This case study was first published in our Year in Review 2024/25 report.
Founded in 2023, Agteria Biotech has developed a patent-pending molecule that reduces methane emissions from dairy cows and beef cattle.
The company’s solution has already demonstrated promising results in several animal trials, including a trial run by Penn State University which showed methane emissions from dairy cows were reduced by up to 30% after consuming a small dose of Agteria Biotech’s molecule as a feed additive.
In February 2025, AgriZeroNZ co-led Agteria Biotech’s seed funding round, alongside Swedish venture capital fund Industrifonden, which saw it raise EUR €6m to further develop the product.
This early-stage funding ensures Agteria Biotech prioritises commercialising in New Zealand, alongside its home region of Europe.
Once the round was closed, the Agteria Biotech team wasted no time in getting to New Zealand to learn more about pasture-based farm systems and the path to market for their product.
AgriZeroNZ facilitated the week-long visit in April 2024 which saw CEO Martin Blomberg and Chief Operating Officer Maia Lidbeck meet with regulators, feed manufacturers, processors and farmers.
“New Zealand presents a strong early-market opportunity due to its sense of urgency and openness to partner.
Martin Blomberg, Agteria Biotech CEO
The company has since started working with a New Zealand regulatory consultant and also completed a twice-daily feeding trial with 120 grazing heifers in Waikato.
Martin says they’re aiming to have their first product, a feed additive, available to New Zealand farmers in 2027, subject to regulatory approval.
“We’re carrying out comprehensive safety studies and animal trials to fine-tune the product and advance towards regulatory approvals.”
Martin says given the molecule’s small size and low daily dosage required, it has the potential to be delivered to animals in other ways, such as a bolus.
AgriZeroNZ is pleased to be backing the Swedish company to accelerate its product development and provide New Zealand farmers priority access to it.
